Overview
Highlights from the 14th Annual Linda Morgante MS Nurse Leadership Program
Click the"View Activity" button to view this activity.
View ActivityActivity already occured. CME/CE is no longer available for this activity
587033.jpg)
Nurses play a vital role in helping patients with multiple sclerosis (MS) live their best possible lives. This on-demand course features highlights from the 14th Annual Linda Morgante MS Nurse Leadership Program. Whether you are new to the field of MS or have years of experience, this program helps nurses explore their evolving role in helping patients navigate this unpredictable disease. Using real life patient testimonials, faculty will guide learners through nurse-led strategies for monitoring and managing symptoms, evaluating medication changes, managing physical limitations, and addressing the disease’s psychosocial implications.
Linda Morgante worked tirelessly as an MS nurse and touched the lives of thousands of physicians, nurses, as well as patients and their families. Linda inspired her students to strive for excellence in nursing and this program is named after her legacy.
This activity is intended for nurses and advanced practice clinicians who manage patients with multiple sclerosis.
The treatment of MS has evolved such that there are now a multitude of approved disease-modifying therapies for clinicians and patients to choose from when managing the disease. However, selection of the optimal medication for an individual patient remains an issue given a lack of guidance, variations in practice/across practitioners, and disease heterogeneity. Additionally, despite the evolution of DMTs, medication compliance over the long-term remains challenging. Nurses are tasked with ensuring patient wellness despite these hurdles. Education of this target audience remains critical in the face of outcomes-driven patient care and with respect to diagnosis, adverse event and symptom management, and coordination of care. This enduring activity, featuring highlights from the 14th Annual Linda Morgante MS Nurse Leadership Program, provides nurses access to knowledge and strategies which they can take back to their practices, to implement in the service of comprehensive patient care and improved outcomes.
Upon completion of this activity, learners will be able to:
•Apply evidence-based diagnostic and assessment approaches for evaluating disease activity in the brain and spinal cord to develop individualized treatment plans in patients with MS
•Apply evidence-based diagnostic and assessment approaches for evaluating disease activity in the brain and spinal cord to develop individualized treatment plans in patients with MS
•Evaluate patient outcomes and adherence to therapy by identifying, assessing, and managing emerging MS-related symptoms and DMT-related adverse events.
•Employ treat-to-target strategies and precision medicine to improve patient long-term outcomes
Provided by the Academy for Continued Healthcare Learning (ACHL) and Annenberg Center for Health Sciences at Eisenhower.
Supported by educational grants from Bristol Myers Squibb, Novartis Pharmaceuticals Corporation, and EMD Serono, Inc.
Co-chairs
Colleen Harris, MN, NP
Nurse Practitioner Manager
University of Calgary MS Clinic
Calgary, Alberta, Canada
Amy Perrin Ross, APN, MSN
Neuroscience Program Coordinator
Loyola University Chicago Medical Center
Maywood, Illinois
Faculty:
Aliza Ben-Zacharia, PhD, DNP, ANP-BC, FAAN
Assistant Professor
Hunter College NY and Mount Sinai School of Nursing
Nurse Practitioner
NP Adult Health Practice PC
New York, New York
Michelle Keating, RN, MSCN
Nurse Consultant
President of MS Bright Spots of Hope
St. Louis, Missouri
Colleen Harris, MN, NP
Nurse Practitioner Manager
University of Calgary MS Clinic
Calgary, Alberta, Canada
Amy Perrin Ross, APN, MSN
Neuroscience Program Coordinator
Loyola University Chicago Medical Center
Maywood, Illinois
Faculty:
Aliza Ben-Zacharia, PhD, DNP, ANP-BC, FAAN
Assistant Professor
Hunter College NY and Mount Sinai School of Nursing
Nurse Practitioner
NP Adult Health Practice PC
New York, New York
Michelle Keating, RN, MSCN
Nurse Consultant
President of MS Bright Spots of Hope
St. Louis, Missouri
Beverly Layton, RN, MSCN, BSN
MS Nurse Consultant
Birmingham, Alabama
Lynn McEwan, MScN
Nurse Practitioner
London Health Sciences Centre-University Hospital
London, Ontario Canada
Marie Namey APRN, MSCN-e
Independent MS Nurse Consultant
Cleveland, Ohio
Patricia Pagnotta, APRN
Nursing Clinical Preceptor
University of Central Florida
Neurology Associates and MS Center of Greater Orlando
Orlando, Florida
The Annenberg Center for Health Sciences at Eisenhower and the Academy for Continued Healthcare Learning (ACHL) require that the faculty participating in an accredited continuing education activity disclose all affiliations or other financial relationships within 24 months (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any ineligible companies. All relevant financial relationships have been mitigated prior to this activity.
Colleen Harris, MN, NP (Chair)
Consulting Agreements: Novartis; Sanofi Genzyme; EMD Serono
Amy Perrin Ross, APN, MSN (Chair)
Consulting Agreements: Alexion; Argenx; BMS; Cycle Pharma; EMD Serono; Genzyme; Horizon
Board Member: CMSC; IOMSN
Aliza Ben-Zacharia, PhD, DNP, ANP-BC, FAAN
Consulting Agreements: Biogen; EMD Serono
Beverly Layton, RN, BSN
Consulting Agreements: Sanofi Genzyme
Lynn McEwan, NP, MScN
Consulting Agreements: Roche; Sanofi Genzyme
The following faculty have no relevant financial relationships to disclose:
Michelle Keating, RN, MSCN
Marie Namey APRN, MSCN
Tricia Pagnotta, APRN
ACHL and Annenberg Center staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
This activity will take a maximum of 2.25 hours to complete. To receive credit, learners are required to complete the pretest, view the online activity, and complete the posttest and evaluation. To receive credit, 66% must be achieved on the posttest. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.
For questions, contact Katie Hacias at khacias@achlcme.org.
The Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 2.25 ANCC contact hours.
The content for this activity was developed independently of any ineligible company. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor(s).
This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.
